Receipt of definitive therapy in elderly patients with unfavorable‐risk prostate cancer
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30948
Abstract: Conservative management of aggressive prostate cancer in the elderly without definitive therapy has been associated with a 10‐year prostate cancer‐specific mortality of approximately 50%. The authors examined the prevalence of definitive therapy in elderly patients… read more here.
Keywords: cancer; definitive therapy; risk; prostate cancer ... See more keywords
Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study
Sign Up to like & getrecommendations! Published in 2018 at "BMC Infectious Diseases"
DOI: 10.1186/s12879-018-2978-z
Abstract: BackgroundStudies have shown that the prognosis of the treatment of methicillin-susceptible S. aureus (MSSA) with glycopeptides is inferior compared to treatment with β-lactam. However, there are only few studies comparing treatment with antistaphylococcal penicillin alone… read more here.
Keywords: mssa bacteremia; treatment; group; definitive therapy ... See more keywords
A Case of Definitive Therapy in Persistent Congenital Hyperthyroidism Secondary to an Activating Variant of the TSHR Gene
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvab048.1407
Abstract: Abstract Background: Sporadic congenital non-autoimmune hyperthyroidism (SCNAH) causes permanent hyperthyroidism secondary to activating mutations in the TSHR gene. SCNAH usually presents during infancy and can be difficult to treat with antithyroid drugs or subtotal thyroidectomy.1… read more here.
Keywords: definitive therapy; growth; case; tshr gene ... See more keywords
Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections
Sign Up to like & getrecommendations! Published in 2022 at "Yonsei Medical Journal"
DOI: 10.3349/ymj.2022.63.7.611
Abstract: Purpose This study aimed to provide compelling evidence of anti-staphylococcal beta-lactam use for methicillin-susceptible Staphylococcus aureus bloodstream infection (MSSA BSI). Materials and Methods We retrospectively collected data on patients with MSSA BSI who were admitted… read more here.
Keywords: aureus bloodstream; methicillin susceptible; staphylococcus aureus; definitive therapy ... See more keywords